The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas

Background: Although, standard treatment of Papillary Thyroid Carcinoma (PTC), involving surgery followed by radioactive iodine (RAI) therapy, is curative for most patients, 5-20% of patients develop RAI refractory disease. The repertoire of genomic events enabling RAI refractory disease in PTC need...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Endocr Soc
Egile Nagusiak: Al-Kuraya, Khawla Sami, Siraj, Sarah, Masoodi, Tariq, Siraj, Abdul Khalid, Azam, Saud, Qadri, Zeeshan, Al-Dayel, Fouad
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2021
Gaiak:
Thyroid
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090190/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1779
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak